On May 12th the president signed an executive order that seeks to force drugmakers to reduce their prices in America to align ...

Congressional Democrats who praised former President Joe Biden’s executive actions against America’s pharmaceutical industry are holding their praise for President Trump’s latest executive order.

US President Donald Trump’s latest executive order seeks to slash prices of prescription drugs by 30-80%. The idea behind the ...

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

Tariffs, executive orders, FTC probes are just some of the problems piling up for the pharmaceutical industry. Trump's ...

Donald Trump's executive order targeting international consumer price parity for prescription drugs in the US faces implementation challenges and potential legal battles. While unlikely to ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

Industry executives feel that the direct-to-government sales could open new channels, giving generic manufacturers some ...

Swiss pharma company Roche (ROG.SW, RHHBY) is warning that its investment into the US could be at risk due to President Trump ...